Insider-Transaktionen (12 Monate) ⓘ
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fondsaktivität (Vorquartalsvergleich) ⓘ
Keine Fondsdaten für dieses Unternehmen vorhanden.
Top-Fondshalter (Stand: 30.09.2025) ⓘ
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfügbar. Stand der gezeigten 13F-Holdings: 30.09.2025. Letztes global veröffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| XTX Topco Ltd | 179.184 | 42.753 | +319,1% | 0 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.09.2025 | ✓ | 2 | 0,2 | 0 |
| 30.06.2025 | ✓ | 74 | 41,5 | 82 |
| 31.03.2025 | ✓ | 80 | 43,6 | 63 |
| 31.12.2024 | ✓ | 75 | 46,4 | 95 |
| 30.09.2024 | vorl. | 77 | 44,6 | 76 |
| 30.06.2024 | vorl. | 92 | 46,9 | 627 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| EcoR1 Capital, LLC | 2.420.243 | 4.816.284 |
| RBF Capital, LLC | 200.000 | 398.000 |
| Rangeley Capital, LLC | 153.790 | 306.042 |
| Y-Intercept (Hong Kong) Ltd | 109.153 | 217.214 |
| Militia Capital Partners, LP | 71.606 | 142.496 |
| Qube Research & Technologies Ltd | 49.963 | 99.426 |
| Quadrature Capital Ltd | 30.942 | 61.575 |
| Jain Global LLC | 30.257 | 60.211 |
| CITADEL ADVISORS LLC | 30.196 | 60.090 |
| Cubist Systematic Strategies, LLC | 26.493 | 52.721 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 308.595 | 142.825 | +86.2 % | 611 |
| TWO SIGMA ADVISERS, LP | 211.600 | 109.224 | +106.7 % | 421.084 |
| TWO SIGMA INVESTMENTS, LP | 170.209 | 79.494 | +87.6 % | 338.716 |
| BML Capital Management, LLC | 91.913 | 71.153 | +342.7 % | 182.907 |
| GSA CAPITAL PARTNERS LLP | 78.466 | 54.914 | +233.2 % | 156 |
| Squarepoint Ops LLC | 61.997 | 42.142 | +212.2 % | 123.374 |
| RENAISSANCE TECHNOLOGIES LLC | 54.100 | 26.500 | +96.0 % | 107.659 |
| MILLENNIUM MANAGEMENT LLC | 176.327 | 21.543 | +13.9 % | 350.891 |
| XTX Topco Ltd | 42.753 | 18.262 | +74.6 % | 85.078 |
| Trium Capital LLP | 395.188 | 16.983 | +4.5 % | 786.424 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| BlackRock, Inc. | 387.533 | -1.707.979 | -81.5 % | 771.191 |
| STATE STREET CORP | 110.264 | -489.865 | -81.6 % | 219.425 |
| MORGAN STANLEY | 174.906 | -480.771 | -73.3 % | 348.064 |
| GEODE CAPITAL MANAGEMENT, LLC | 255.254 | -353.679 | -58.1 % | 508.156 |
| GOLDMAN SACHS GROUP INC | 460.505 | -195.206 | -29.8 % | 916.405 |
| BANK OF AMERICA CORP /DE/ | 929 | -183.732 | -99.5 % | 1.848 |
| NORTHERN TRUST CORP | 62.134 | -164.395 | -72.6 % | 123.647 |
| VANGUARD GROUP INC | 1.451.205 | -134.463 | -8.5 % | 2.887.898 |
| Verition Fund Management LLC | 37.625 | -79.130 | -67.8 % | 74.874 |
| JPMORGAN CHASE & CO | 2.598 | -45.418 | -94.6 % | 5.170 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 14.11.2025 | Oleg Nodelman | Passiv (13G/A) | Ausstieg | 0 | -5,80 pp | |
| 14.11.2025 | EcoR1 Capital Fund Qualified, L.P. | Passiv (13G/A) | Ausstieg | 0 | -5,40 pp | |
| 14.11.2025 | EcoR1 Capital, LLC | Passiv (13G/A) | Ausstieg | 0 | -5,80 pp | |
| 19.09.2025 | Takeda Pharmaceutical Company Limited | Aktivist (13D/A) | Ausstieg | 0 | -17,10 pp | The cash tender offer (the "Tender Offer") by XOMA Royalty Corporation, a Nevada corpora… |
| 19.09.2025 | Takeda Vaccines Inc. | Aktivist (13D/A) | Ausstieg | 0 | Neu | The cash tender offer (the "Tender Offer") by XOMA Royalty Corporation, a Nevada corpora… |
| 19.09.2025 | TANG CAPITAL MANAGEMENT, LLC | Aktivist (13D/A) | Ausstieg | 0 | -9,80 pp | Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: … |
| 19.09.2025 | TANG CAPITAL PARTNERS, LP | Aktivist (13D/A) | Ausstieg | 0 | -5,50 pp | Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: … |
| 19.09.2025 | TANG CAPITAL PARTNERS III, INC | Aktivist (13D/A) | Ausstieg | 0 | 0,00 pp | Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: … |
| 19.09.2025 | TANG CAPITAL PARTNERS INTERNATIONAL, LP | Aktivist (13D/A) | Ausstieg | 0 | -4,30 pp | Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: … |
| 19.09.2025 | CONCENTRA BIOSCIENCES, LLC | Aktivist (13D/A) | Ausstieg | 0 | 0,00 pp | Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: … |
| 19.09.2025 | KEVIN TANG | Aktivist (13D/A) | Ausstieg | 0 | -9,80 pp | Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: … |
| 19.09.2025 | TANG CAPITAL PARTNERS IV, INC | Aktivist (13D/A) | Ausstieg | 0 | 0,00 pp | Item 4 of the Schedule 13D is amended by adding the following: Closing of the Merger: … |
| 17.09.2025 | Patrick J. Heron | Aktivist (13D/A) | Ausstieg | 0 | -25,00 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | FHMLSP, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -3,20 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | FHMLS XI, L.P. | Aktivist (13D/A) | Ausstieg | 0 | Neu | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | FHMLS XI, L.L.C. | Aktivist (13D/A) | Ausstieg | 0 | Neu | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | James N. Topper | Aktivist (13D/A) | Ausstieg | 0 | -25,00 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | James Brush | Aktivist (13D/A) | Ausstieg | 0 | -3,20 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | Albert Cha | Aktivist (13D/A) | Ausstieg | 0 | -3,20 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | Frazier Life Sciences XI, L.P. | Aktivist (13D/A) | Ausstieg | 0 | Neu | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | FHMLSP Overage, L.P. | Aktivist (13D/A) | Ausstieg | 0 | Neu | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | FHMLS X, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -21,80 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | Frazier Life Sciences X, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -21,80 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | FHMLS X, L.L.C. | Aktivist (13D/A) | Ausstieg | 0 | -21,80 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | FHMLSP Overage, L.L.C. | Aktivist (13D/A) | Ausstieg | 0 | Neu | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | Daniel Estes | Aktivist (13D/A) | Ausstieg | 0 | Neu | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | Frazier Life Sciences Public Overage Fund, L.P. | Aktivist (13D/A) | Ausstieg | 0 | Neu | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | FHMLSP, L.L.C. | Aktivist (13D/A) | Ausstieg | 0 | -3,20 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 17.09.2025 | Frazier Life Sciences Public Fund, L.P. | Aktivist (13D/A) | Ausstieg | 0 | -3,20 pp | Item 4 of the Schedule 13D is hereby amended to incorporate the following at the end the… |
| 24.07.2025 | EcoR1 Capital, LLC | Passiv (13G) | 5,80 % | 2.892.000 | Neu | |
| 24.07.2025 | Oleg Nodelman | Passiv (13G) | 5,80 % | 2.892.000 | Neu | |
| 24.07.2025 | EcoR1 Capital Fund Qualified, L.P. | Passiv (13G) | 5,40 % | 2.709.498 | Neu | |
| 02.05.2025 | CONCENTRA BIOSCIENCES, LLC | Aktivist (13D) | Ausstieg | 0 | Neu | The Reporting Persons are filing this Statement as an amendment to their Schedule 13G pr… |
| 02.05.2025 | KEVIN TANG | Aktivist (13D) | 9,80 % | 4.920.000 | Neu | The Reporting Persons are filing this Statement as an amendment to their Schedule 13G pr… |
| 02.05.2025 | TANG CAPITAL PARTNERS IV, INC | Aktivist (13D) | Ausstieg | 0 | Neu | The Reporting Persons are filing this Statement as an amendment to their Schedule 13G pr… |
| 02.05.2025 | TANG CAPITAL PARTNERS III, INC | Aktivist (13D) | Ausstieg | 0 | Neu | The Reporting Persons are filing this Statement as an amendment to their Schedule 13G pr… |
| 02.05.2025 | TANG CAPITAL MANAGEMENT, LLC | Aktivist (13D) | 9,80 % | 4.920.000 | Neu | The Reporting Persons are filing this Statement as an amendment to their Schedule 13G pr… |
| 02.05.2025 | TANG CAPITAL PARTNERS INTERNATIONAL, LP | Aktivist (13D) | 4,30 % | 2.152.992 | Neu | The Reporting Persons are filing this Statement as an amendment to their Schedule 13G pr… |
| 02.05.2025 | TANG CAPITAL PARTNERS, LP | Aktivist (13D) | 5,50 % | 2.767.008 | Neu | The Reporting Persons are filing this Statement as an amendment to their Schedule 13G pr… |
| 14.11.2024 | Deerfield Partners, L.P. | Passiv (13G/A) | Ausstieg | 0 | -4,38 pp |
Stammdaten
Unternehmen & Branche
| Name | HilleVax, Inc. |
|---|---|
| Ticker | |
| CIK | 0001888012 |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
Externe Quelle: SEC EDGAR »
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.08.2025 | 10-Q | 30.06.2025 | 37 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 28.03.2025 | 10-K | 31.12.2024 | 87 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 09.08.2024 | 10-Q | 30.06.2024 | 40 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 20.03.2024 | 10-K | 31.12.2023 | 80 Tage | SEC » |
| 09.11.2023 | 10-Q | 30.09.2023 | 40 Tage | SEC » |
| 14.08.2023 | 10-Q | 30.06.2023 | 45 Tage | SEC » |
| 12.05.2023 | 10-Q | 31.03.2023 | 42 Tage | SEC » |
| 17.03.2023 | 10-K | 31.12.2022 | 76 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 17.09.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n Form 8-K is incorporated by reference into this Item 5.02. In connection with the consummation of the Merger, each of… |
| 05.12.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | implementation of the workforce reduction. Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 18.01.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment… |